Search

everythinglearnresearchcommunity

for

Search:↓

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Central lipohypertrophy in HIV-infected women may lead to shorter eyelashes.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Auto-portraits help evaluate scalp hair.

ILC1 cells contribute to hair loss in alopecia areata.

Dilated pupils can be an early sign of HIV/AIDS.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Polysaccharides have many health benefits and are used in drugs, but isolating and purifying them is complex and requires careful methods.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Inflammation affects hair loss; anti-inflammatory treatments may help.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Skin diseases are common in HIV patients and could help detect HIV early in Ethiopia.